Cerecin
ID: 5332178Cerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.
7
Funding Rounds
$189.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Cerecin has raised a total of $189.5m in funding over 7 rounds.
Key Insights:
- Cerecin Funding Round, August 2022: $40m
- Cerecin Series A round, October 2021: $40m
- Cerecin Funding round, October 2018: $50m
- Accera Series D round: $11m
- Accera Series C round: $35m
- Accera Series B round: $7.5m
- Accera Series A round: $6m
Industries
Cerecin is active in the following industries: